Molecular MRI of hematopoietic stem-progenitor cells: in vivo monitoring of gene therapy and atherosclerosis.
A characteristic feature of atherosclerotic cardiovascular disease is the diffuse involvement of arteries across the entire human body and the presence of multiple, simultaneous lesions. The diffuse nature of this disease creates a unique challenge for early diagnosis and effective treatment. We believe that recent progress in the field of molecular MRI has opened new avenues towards solving the problem. A new technology has been developed that uses molecular MRI to monitor the migration and homing of hematopoietic stem-progenitor cells to injured arteries and atherosclerosis. In this Review, we introduce several novel technical developments in the field of molecular MRI of atherosclerosis, including advanced techniques for magnetic labeling of stem-progenitor cells and molecular MRI of hematopoietic bone marrow cells migrating to injured arteries and homing to atherosclerotic plaques. In addition, we examine molecular MRI of vascular gene therapy mediated by stem-progenitor cells. These new techniques provide the basis for the further development of in vivo MRI techniques to monitor stem-cell-mediated vascular gene therapy for multiple and diffuse atherosclerotic cardiovascular lesions.
Qiu
Bensheng
B
Image-Guided Bio-Molecular Interventions Section, Department of Radiology, University of Washington School of Medicine, 1959 NE Pacific Street, HSC AA-036, Seattle, WA 98195, USA.
Yang
Xiaoming
X
D050197:Atherosclerosis / Q000175:diagnosis* / Q000628:therapy*; D015316:Genetic Therapy; D006412:Hematopoietic Stem Cells; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*